Migraine Pain Freedom: Make it Possible with Relivion® MG
Location: United States, Florida, Tampa
Mentions in press and media 6
| Date | Title | Description |
| 02.01.2024 | Neurolief Announces Strategic Equity Investment by Sawai Group Holdings | Neurolief, a global leader in medical devices delivering groundbreaking neurotechnology innovations for the treatment of Neurological and Neuropsychiatric disorders, is pleased to announce a strategic equity investment from Sawai Group Hold... |
| 13.12.2022 | Neurolief Appoints Neuromodulation Industry Leader Scott Drees as CEO | As a 27-year pioneer in neuromodulation, Scott is a proven leader, whose experience in neuromodulation positions him to take Neurolief to its next phase of growth.” — Raphael Ben Dror, Neurolief Chairman of the Board TAMPA, FL, UNITED STATE... |
| 12.09.2022 | See the 22-slide presentation an Israeli startup used to raise $45 million for an easier way to treat migraines | Theranica's CEO and founder, Alon Ironi Theranica This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Israeli healthcare startup Theranica just raised a $25 million Series C round. The compan... |
| 29.06.2022 | Neurolief Announces Publication of the RIME Pivotal Study for Relivion MG – a Digital Therapeutics Platform for Migraine | Results of clinical study demonstrate non-invasive combined occipital and trigeminal neuromodulation system may offer pronounced benefit for migraine patients. TAMPA, FL, UNITED STATES, June 29, 2022 /EINPresswire.com/ -- Neurolief, a neuro... |
| 14.06.2022 | New Data Demonstrates Substantial Reduction of Migraine Days Using Neurolief’s Digital Therapeutics Technology | 85% of patients achieved at least a 50% reduction in monthly migraine days using the eCOT-NS technology system, according to real-world, open-label analysis TAMPA, FL, USA, June 14, 2022 /EINPresswire.com/ -- Neurolief, a neurotechnology in... |
| 09.06.2022 | Neurolief’s Digital Therapeutics Neuromodulation System May Challenge Medication Therapies for the Treatment of Migraine | Study shows 76% of patients treated with Relivion achieved headache pain relief at 2 hours TAMPA, FL, USA, June 9, 2022 /EINPresswire.com/ -- Neurolief, a neurotechnology innovator, today announces the publication of the SP301 study in the ... |